Pregnancy-Related Thromboembolism

  1. Arumugam Manoharan, MD
  1. St. George Hospital; Kogarah, Sydney, Australia

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    TO THE EDITOR:

    I read with interest the informative article by Friederich and colleagues [1] and the editorial by Lee [2] on thromboembolic disease and pregnancy. Low-molecular-weight heparin, recommended by Friederich and colleagues and Lee, has been effectively and safely used for thromboprophylaxis during pregnancy [3, 4]. However, no information seems to be available about the drug's safety in relation to breast feeding, and drug companies advise against its use during the puerperium in breast-feeding patients. I would appreciate the authors' comments on this issue.

    Arumugam Manoharan, MD

    St. George Hospital; Kogarah, Sydney, Australia

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    References

    1. 1.
    2. 2.
    3. 3.
    4. 4.
    « Previous | Next Article »Table of Contents

    Navigate This Article